Predicting eligibility for outpatient 177Lu-DOTATATE-targeted radionuclide therapy in patients with neuroendocrine tumors
The whole-body washout rate derived from pretreatment SSTR imaging is a strong, practical predictor for outpatient eligibility following 177Lu-DOTATATE TRT. Incorporating this simple, noninvasive marker into clinical workflow could support individualized discharge planning and improve patient access under strict radiation safety regulations.
Authors
- Hidetoshi Shimizu (ORCID: https://orcid.org/0000-0002-6633-0964)
- Isanori Iwama
- Yasunori Ishiguro
- Yuichiro Furuya
- Yoshitaka Inaba (ORCID: https://orcid.org/0000-0002-0850-6327)
- Masakazu Tsujimoto (ORCID: https://orcid.org/0000-0003-2980-5366)
- Naoki Hayashi
- Tsubasa Asai
- Hiroyuki Tachibana
Institutions
- Fujita Health University (JP)
- Aichi Cancer Center (JP)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1097/mnm.0000000000002110
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00